| Literature DB >> 18431552 |
Won Seog Kim1, Yeon Hee Park, Se-Hoon Lee, Baek-Yeol Ryoo, Sung Hyun Yang, Seung-Sook Lee, Mi Sook Kim, Kihyun Kim, Keon Woo Park, Do Hyoung Im, Jung Hun Kang, Jeeyun Lee, Young H Ko, Yong Chan Ahn, Do Hoon Lim, Keunchil Park, Soo-Mee Bang.
Abstract
We assessed the quality of life (QOL) at least one year after sequential chemoradiotherapy for the treatment of localized gastric diffuse large B-cell lymphoma (DLBCL). We used the EORTC Quality of Life Questionnaire for Stomach Cancer (EORTC QLQ-STO22). Among the 45 patients available at the one-year follow-up after radiation therapy, 40 patients completed the EORTC QLQ-STO22 questionnaire. Their median age was 54.5 (range, 20-70 years). Social functioning was most adversely affected among the respondents with a score of 59, whereas other functions and the global scales were preserved above a score of 70 by linearly transformed values. Fatigue, the financial impact and specific emotional problems such as "thinking about their illness" (STO-ANX) and "worry about weight loss or future health" (STO-BI) were persistently bothersome for some patients. Other stomach-related symptoms such as dysphagia, pain, or reflux were negligible at 1 year after treatment. Therefore, this organ-preserving combined approach was effective for the maintenance of the QOL and minimization of stomach abnormalities in patients with gastric lymphoma.Entities:
Mesh：
Substances：
Year: 2008 PMID： 18431552 DOI： 10.1007/s12032-008-9065-z
Source DB: PubMed Journal: Med Oncol ISSN： 1357-0560 Impact factor: 3.064